Search Results - "Hessel, Edith"

Refine Results
  1. 1

    PI3K inhibitors in inflammation, autoimmunity and cancer by Stark, Anne-Katrien, Sriskantharajah, Srividya, Hessel, Edith M, Okkenhaug, Klaus

    Published in Current opinion in pharmacology (01-08-2015)
    “…Highlights • Preclinical studies support us of PI3K inhibitors in autoimmunity and inflammation. • First in class PI3K inhibitor has been approved for…”
    Get full text
    Journal Article
  2. 2

    Functions of T cells in asthma: more than just TH2 cells by Lloyd, Clare M., Hessel, Edith M.

    Published in Nature reviews. Immunology (01-12-2010)
    “…Key Points Several T cell subsets are involved in the development of the diseases we call asthma, not just T helper 2 (T H 2) cells. Emerging data describe the…”
    Get full text
    Journal Article
  3. 3

    Functions of T cells in asthma: more than just T(H)2 cells by Lloyd, Clare M, Hessel, Edith M

    Published in Nature reviews. Immunology (01-12-2010)
    “…Asthma has been considered a T helper 2 (T(H)2) cell-associated inflammatory disease, and T(H)2-type cytokines, such as interleukin-4 (IL-4), IL-5 and IL-13,…”
    Get full text
    Journal Article
  4. 4

    Influenza-induced monocyte-derived alveolar macrophages confer prolonged antibacterial protection by Aegerter, Helena, Kulikauskaite, Justina, Crotta, Stefania, Patel, Harshil, Kelly, Gavin, Hessel, Edith M., Mack, Matthias, Beinke, Soren, Wack, Andreas

    Published in Nature immunology (01-02-2020)
    “…Despite the prevalence and clinical importance of influenza, its long-term effect on lung immunity is unclear. Here we describe that following viral clearance…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7

    IFNλ is a potent anti‐influenza therapeutic without the inflammatory side effects of IFNα treatment by Davidson, Sophia, McCabe, Teresa M, Crotta, Stefania, Gad, Hans Henrik, Hessel, Edith M, Beinke, Soren, Hartmann, Rune, Wack, Andreas

    Published in EMBO molecular medicine (01-09-2016)
    “…Influenza A virus (IAV)‐induced severe disease is characterized by infected lung epithelia, robust inflammatory responses and acute lung injury. Since type I…”
    Get full text
    Journal Article
  8. 8

    Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists by Kanzler, Holger, Barrat, Franck J, Hessel, Edith M, Coffman, Robert L

    Published in Nature medicine (01-05-2007)
    “…The identification of the antigen recognition receptors for innate immunity, most notably the Toll-like receptors, has sparked great interest in therapeutic…”
    Get full text
    Journal Article
  9. 9

    Airway host-microbiome interactions in chronic obstructive pulmonary disease by Wang, Zhang, Maschera, Barbara, Lea, Simon, Kolsum, Umme, Michalovich, David, Van Horn, Stephanie, Traini, Christopher, Brown, James R, Hessel, Edith M, Singh, Dave

    Published in Respiratory research (06-06-2019)
    “…Little is known about the interactions between the lung microbiome and host response in chronic obstructive pulmonary disease (COPD). We performed a…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Development of a Novel Quantitative Structure-Activity Relationship Model to Accurately Predict Pulmonary Absorption and Replace Routine Use of the Isolated Perfused Respiring Rat Lung Model by Edwards, Chris D., Luscombe, Chris, Eddershaw, Peter, Hessel, Edith M.

    Published in Pharmaceutical research (01-11-2016)
    “…Purpose We developed and tested a novel Quantitative Structure-Activity Relationship (QSAR) model to better understand the physicochemical drivers of pulmonary…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Safety, Tolerability, and Pharmacokinetics of a New Formulation of Nemiralisib Administered via a Dry Powder Inhaler to Healthy Individuals by Wilson, Robert, Templeton, Alison, Leemereise, Claudia, Eames, Rhena, Banham-Hall, Edward, Hessel, Edith M., Cahn, Anthony

    Published in Clinical therapeutics (01-06-2019)
    “…Nemiralisib, a phosphoinositide 3-kinase δ inhibitor, is being investigated as an immunomodulatory agent with anti-inflammatory properties in chronic…”
    Get full text
    Journal Article
  14. 14

    Membrane nanoclusters of FcγRI segregate from inhibitory SIRPα upon activation of human macrophages by Lopes, Filipa B, Bálint, Štefan, Valvo, Salvatore, Felce, James H, Hessel, Edith M, Dustin, Michael L, Davis, Daniel M

    Published in The Journal of cell biology (03-04-2017)
    “…Signal integration between activating Fc receptors and inhibitory signal regulatory protein α (SIRPα) controls macrophage phagocytosis. Here, using dual-color…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Corrected Super-Resolution Microscopy Enables Nanoscale Imaging of Autofluorescent Lung Macrophages by Ambrose, Ashley R., Dechantsreiter, Susanne, Shah, Rajesh, Montero, M. Angeles, Quinn, Anne Marie, Hessel, Edith M., Beinke, Soren, Tannahill, Gillian M., Davis, Daniel M.

    Published in Biophysical journal (15-12-2020)
    “…Observing the cell surface and underlying cytoskeleton at nanoscale resolution using super-resolution microscopy has enabled many insights into cell signaling…”
    Get full text
    Journal Article
  17. 17

    Intranasal Bifidobacterium longum protects against viral-induced lung inflammation and injury in a murine model of lethal influenza infection by Groeger, David, Schiavi, Elisa, Grant, Ray, Kurnik-Łucka, Magdalena, Michalovich, David, Williamson, Rick, Beinke, Soren, Kiely, Barry, Akdis, Cezmi A, Hessel, Edith M, Shanahan, Fergus, O’ Mahony, Liam

    Published in EBioMedicine (01-10-2020)
    “…Prophylactic strategies are urgently needed for prevention of severe inflammatory responses to respiratory viral infections. Bacterial-host interactions may…”
    Get full text
    Journal Article
  18. 18
  19. 19

    The effects of repeated Toll-like receptors 2 and 4 stimulation in COPD alveolar macrophages by Lea, Simon R, Reynolds, Sophie L, Kaur, Manminder, Simpson, Karen D, Hall, Simon R, Hessel, Edith M, Singh, Dave

    “…COPD is a progressive inflammatory airway disease characterized by increased numbers of alveolar macrophages in the lungs. Bacterial colonization of the lungs…”
    Get full text
    Journal Article
  20. 20

    Safety, Tolerability, and Pharmacokinetics of Single and Repeat Doses of Nemiralisib Administered via the Ellipta Dry Powder Inhaler to Healthy Subjects by Wilson, Robert, Jarvis, Emily, Montembault, Mickael, Hamblin, J. Nicole, Hessel, Edith M., Cahn, Anthony

    Published in Clinical therapeutics (01-08-2018)
    “…Novel therapies to treat chronic obstructive pulmonary disease are highly desirable. The safety, tolerability, and pharmacokinetic (PK) parameters of…”
    Get full text
    Journal Article